Prognosis
Moderna Sees Annual US Market for Covid-19 Shots Ranging Up to $13 Billion
- Prices, health officials’ recommendations play into estimates
- Biotech will go up against Pfizer as consumer sales begin
A healthcare worker grabs a vial of the Moderna vaccine for Covid-19 in Munich, Germany.
Photographer: Michaela Handrek-Rehle/BloombergThis article is for subscribers only.
Annual US sales of Covid-19 shots could be high as $12.9 billion, with health officials likely recommending an annual booster, vaccine maker Moderna Inc. said in a meeting with investors.
Exactly how big the market will be for shots made by the company and its rivals depends on who keeps receiving boosters, Moderna said. It could be as little as $5.2 billion annually, depending on shots’ prices and how many people receive them, officials said Thursday in a meeting with investors in Boston.